Organogenesis Holdings
ORGO
0 hedge funds and large institutions have $0 invested in Organogenesis Holdings in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.
100% less funds holding
Funds holding: 27 → 0 (-27)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $281M → $0 (-$281M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 27
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$29.8M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$24.1M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$23.1M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$21.2M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
-$17.2M |
ORGO Hedge Fund Activity: Q4 2018 in Review
0 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2018, worth a combined $0 — down 100% from $281M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of ORGO and 0 opened new positions — a net loss of 27 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Glazer Capital LLC, exiting entirely with an estimated $29.8M sold.
- 0 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2018, down from 27 in Q3 2018.
- Funds reported $0 of Organogenesis Holdings stock for Q4 2018, down 100% quarter-over-quarter.
- 0 funds opened new Organogenesis Holdings positions in Q4 2018 and 27 closed out, a net change of -27 holders.
- The largest Organogenesis Holdings seller in Q4 2018 was Glazer Capital LLC, an estimated $29.8M sold.
Based on aggregated 13F filings for Q4 2018.